Jin Medical International Ltd. (ZJYL)
USD 0.8
(9.59%)
USD 0.8
(9.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.78 Million USD | 9.46% |
| 2022 | 6.19 Million USD | -2.56% |
| 2021 | 6.36 Million USD | 15.69% |
| 2020 | 5.49 Million USD | -26.8% |
| 2019 | 7.51 Million USD | -1.91% |
| 2018 | 7.65 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.89 Million USD | -41.65% |
| 2024 Q2 | 1.89 Million USD | 0.0% |
| 2023 Q4 | 3.25 Million USD | 95.3% |
| 2023 FY | 6.78 Million USD | 9.46% |
| 2023 Q1 | 1.81 Million USD | 15.47% |
| 2023 Q2 | 3.53 Million USD | 94.39% |
| 2023 Q3 | 1.66 Million USD | -52.81% |
| 2022 Q4 | 1.57 Million USD | 0.0% |
| 2022 Q3 | 1.57 Million USD | -2.05% |
| 2022 Q2 | 1.6 Million USD | 0.0% |
| 2022 Q1 | 1.6 Million USD | 9.29% |
| 2022 FY | 6.19 Million USD | -2.56% |
| 2021 Q4 | 1.46 Million USD | 0.0% |
| 2021 FY | 6.36 Million USD | 15.69% |
| 2021 Q3 | 1.46 Million USD | -18.56% |
| 2021 Q2 | 1.8 Million USD | -0.0% |
| 2021 Q1 | 1.8 Million USD | 24.28% |
| 2020 Q4 | 1.45 Million USD | 0.0% |
| 2020 FY | 5.49 Million USD | -26.8% |
| 2020 Q1 | 1.29 Million USD | -28.8% |
| 2020 Q2 | 1.29 Million USD | -0.0% |
| 2020 Q3 | 1.45 Million USD | 11.91% |
| 2019 Q1 | 1.93 Million USD | 0.0% |
| 2019 Q4 | 1.82 Million USD | 0.0% |
| 2019 Q2 | 1.93 Million USD | 0.0% |
| 2019 Q3 | 1.82 Million USD | -5.79% |
| 2019 FY | 7.51 Million USD | -1.91% |
| 2018 FY | 7.65 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 87.95% |
| AngioDynamics, Inc. | 154.69 Million USD | 95.614% |
| AtriCure, Inc. | 300.37 Million USD | 97.741% |
| Avinger, Inc. | 2 Million USD | -238.734% |
| Azenta, Inc. | 263.14 Million USD | 97.422% |
| BioLife Solutions, Inc. | 46.75 Million USD | 85.488% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 99.712% |
| Daxor Corporation | 1.1 Million USD | -514.88% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 25.269% |
| Femasys Inc. | 691.9 Thousand USD | -880.608% |
| GlucoTrack, Inc. | -13 Thousand USD | 52291.031% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 88.853% |
| Hologic, Inc. | 2.22 Billion USD | 99.695% |
| ICU Medical, Inc. | 739.87 Million USD | 99.083% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.857% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 59.392% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 94.66% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 5785.822% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 5785.822% |
| Masimo Corporation | 1 Billion USD | 99.324% |
| Microbot Medical Inc. | -106 Thousand USD | 6500.787% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 79.499% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 98.838% |
| Nephros, Inc. | 8.4 Million USD | 19.276% |
| NovoCure Limited | 381.05 Million USD | 98.219% |
| NEXGEL, Inc. | 619 Thousand USD | -996.096% |
| NEXGEL, Inc. | 619 Thousand USD | -996.096% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 1315.92% |
| OraSure Technologies, Inc. | 179.42 Million USD | 96.218% |
| Pro-Dex, Inc. | 14.55 Million USD | 53.372% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 662.124% |
| Predictive Oncology Inc. | 1.14 Million USD | -492.408% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -17.025% |
| QuidelOrtho Corporation | 1.49 Billion USD | 99.546% |
| Repligen Corporation | 315.22 Million USD | 97.848% |
| Sanara MedTech Inc. | 57.13 Million USD | 88.125% |
| STAAR Surgical Company | 252.65 Million USD | 97.315% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 861.273% |
| Utah Medical Products, Inc. | 30.03 Million USD | 77.412% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.675% |